BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25889865)

  • 21. [Analysis of drug - resistant gene polymorphisms in
    Nie GK; Xu C; Wei QK; Li J; Xiao T; Sun H; Kong XL; Yin K; Zhao GH; Zhang BG; Yan G; Huang BC
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Jun; 32(6):612-617. PubMed ID: 33325196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
    Figueiredo P; Benchimol C; Lopes D; Bernardino L; do Rosário VE; Varandas L; Nogueira F
    Malar J; 2008 Nov; 7():236. PubMed ID: 19014684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
    Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
    Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
    Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
    Sugaram R; Suwannasin K; Kunasol C; Mathema VB; Day NPJ; Sudathip P; Prempree P; Dondorp AM; Imwong M
    Malar J; 2020 Mar; 19(1):107. PubMed ID: 32127009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
    Myers-Hansen JL; Abuaku B; Oyebola MK; Mensah BA; Ahorlu C; Wilson MD; Awandare G; Koram KA; Ngwa AA; Ghansah A
    PLoS One; 2020; 15(12):e0233478. PubMed ID: 33284800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin.
    Svigel SS; Adeothy A; Kpemasse A; Houngbo E; Sianou A; Saliou R; Patton ME; Dagnon F; Halsey ES; Tchevoede A; Udhayakumar V; Lucchi NW
    Malar J; 2021 Feb; 20(1):72. PubMed ID: 33546703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria.
    Oboh MA; Singh US; Antony HA; Ndiaye D; Badiane AS; Ali NA; Bharti PK; Das A
    Infect Genet Evol; 2018 Dec; 66():222-228. PubMed ID: 30316883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
    Tarama CW; Soré H; Siribié M; Débé S; Kinda R; Ganou A; Nonkani WG; Tiendrebeogo F; Bantango W; Yira K; Sagnon A; Ilboudo S; Hien EY; Guelbéogo MW; Sagnon N; Traoré Y; Ménard D; Gansané A
    Malar J; 2023 Jul; 22(1):213. PubMed ID: 37474966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pfcrt mutant haplotypes may not correspond with chloroquine resistance.
    Goswami D; Dhiman S; Rabha B; Kumar D; Baruah I; Sharma DK; Veer V
    J Infect Dev Ctries; 2014 Jun; 8(6):768-73. PubMed ID: 24916876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Frequency Mutations in
    Yan H; Feng J; Yin JH; Huang F; Kong XL; Lin KM; Zhang T; Feng XY; Zhou SS; Cao JP; Xia ZG
    Front Cell Infect Microbiol; 2021; 11():673194. PubMed ID: 34568082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.
    Jovel IT; Björkman A; Roper C; Mårtensson A; Ursing J
    Malar J; 2017 Mar; 16(1):113. PubMed ID: 28288632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
    Bwire GM; Mikomangwa WP; Kilonzi M
    BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda.
    Zeile I; Gahutu JB; Shyirambere C; Steininger C; Musemakweri A; Sebahungu F; Karema C; Harms G; Eggelte TA; Mockenhaupt FP
    Acta Trop; 2012 Jan; 121(1):50-4. PubMed ID: 21996622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.
    Gadalla NB; Abdallah TM; Atwal S; Sutherland CJ; Adam I
    Malar J; 2013 Jul; 12():255. PubMed ID: 23870667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
    Ogouyèmi-Hounto A; Ndam NT; Fadégnon G; Azagnandji C; Bello M; Moussiliou A; Chippaux JP; Kinde Gazard D; Massougbodji A
    Malar J; 2013 Nov; 12():413. PubMed ID: 24225351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.